SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Sanara MedTech Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$33.14−0.02 (-0.06%)
Close on Oct 19, 2026
- Market cap
- $287.08M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$4.88 (+17.27%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Sanara MedTech Inc. grew revenue 13.0% to $109.81M over the twelve months to Jun 30, 2026. Operating income rose 32.5% to $8.42M, moving the operating margin from 6.5% to 7.7%. Free cash flow was $4.50M, up 5368.1% from a year earlier.
Revenue
$109.81M
+13.0% vs. a year earlier
Operating income
$8.42M
+32.5% vs. a year earlier
Free cash flow
$4.50M
+5368.1% vs. a year earlier
EPS, diluted
-$3.61
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $287.08M
- P/E ratio
- –
- Price to sales
- 2.61
- Price to book
- 36.14
- Dividend yield
- –
- Free cash flow yield
- 1.57%
Fundamentals
- Revenue
- $109.81M
- Net income
- -$32.01M
- EPS, diluted
- -$3.61
- Free cash flow
- $4.50M
- Book value per share
- $0.92
- Diluted shares
- 9M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$109.81M+13.0% YoY
Gross profit
$102.16M+14.5% YoY
Operating income
$8.42M+32.5% YoY
Net income
-$32.01M
EPS, diluted
-$3.61
Free cash flow
$4.50M+5368.1% YoY
Reported periodTrailing twelve months